13F

Stock

Nektar Therapeutics

NKTR · held by 2 managers

Reported value

$161.1K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$59.2K

Price effect on 2 books still in the name

Largest holder

$161K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC236.8K$161K−$59.2KCut−$142K
Medallion Wealth Advisors, LLC207$141$0Held

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.